Reverse cardiac remodelling and dysfunction in A97S transthyretin cardiac amyloidosis after tafamidis treatment

Transthyretin cardiomyopathy (ATTR‐CM) is an under‐recognized cause of heart failure, but it has received increasing attention due to the availability of treatment options. We present a case of hereditary transthyretin cardiomyopathy (A97S, an under‐represented variant in current clinical studies) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuan‐Kun (Aden), Tsai, Cheng‐Hsuan, Su, Mao‐Yuan, Chao, Chi‐Chao, Cheng, Mei‐Fang, Shun, Chia‐Tung, Hsieh, Sung‐Tsang, Lin, Yen‐Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773766/
https://www.ncbi.nlm.nih.gov/pubmed/36128649
http://dx.doi.org/10.1002/ehf2.14165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773766/
https://www.ncbi.nlm.nih.gov/pubmed/36128649
http://dx.doi.org/10.1002/ehf2.14165

Ejemplares similares